News

Filter

Current filters:

ImbruvicaUSA

1 to 9 of 16 results

AbbVie chief executive defends Pharmacyclics deal in the face of analyst criticism

AbbVie chief executive defends Pharmacyclics deal in the face of analyst criticism

09-03-2015

As analysts question the price AbbVie paid for Pharmacyclics, AbbVie’s chief executive Richard Gonzalez…

AbbVieImbruvicaMergers & AcquisitionsPharmaceuticalPharmacyclicsUSA

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom’s macroglobulinemia

30-01-2015

The US Food and Drug Administration has expanded approval of Johnson & Johnson and Pharmacyclics’ Imbruvica…

HematologyImbruvicaJohnson & JohnsonPharmaceuticalPharmacyclicsRegulationUSA

Pharmacyclics files Imbruvica sNDA for Waldenstrom’s macroglobulinemia

20-10-2014

US drugmaker Pharmacyclics has submitted a supplemental New Drug Application to the US Food and Drug…

ImbruvicaJanssen BiotechJohnson & JohnsonOncologyPharmaceuticalPharmacyclicsRegulationUSA

Pharmacyclics and Roche research Imbruvica and Gazyva

Pharmacyclics and Roche research Imbruvica and Gazyva

17-10-2014

USA-based biopharma company Pharmacyclics has entered into a master clinical drug supply agreement with…

GazyvaImbruvicaOncologyPharmaceuticalPharmacyclicsResearchRocheUSA

AACR report calls for US cancer funding to be a national priority

AACR report calls for US cancer funding to be a national priority

18-09-2014

Declining budgets have slowed the pace of research into cancer, according to a new report from the American…

AbraxaneCyramzaFinancialGazyvaImbruvicaNexavarOncologyPharmaceuticalResearchTafinlarUSAZydelig

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

New entrants in chronic lymphocytic leukemia will raise market value to $3.3 billion by 2018

02-07-2014

The introduction of several new drugs will accelerate growth in the chronic lymphocytic leukemia treatment…

EuropeidelalisibImbruvicaMarkets & MarketingOncologyPharmaceuticalUSA

1 to 9 of 16 results

Back to top